51KB Stock Overview
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AVITA Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.68 |
| 52 Week High | US$3.68 |
| 52 Week Low | US$1.67 |
| Beta | 1.29 |
| 1 Month Change | -42.47% |
| 3 Month Change | -36.84% |
| 1 Year Change | -34.88% |
| 3 Year Change | -47.34% |
| 5 Year Change | -63.32% |
| Change since IPO | -96.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 51KB | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -14.7% | -5.9% | -1.7% |
| 1Y | -34.9% | -21.4% | -0.2% |
Return vs Industry: 51KB underperformed the German Biotechs industry which returned -19.9% over the past year.
Return vs Market: 51KB underperformed the German Market which returned 0.9% over the past year.
Price Volatility
| 51KB volatility | |
|---|---|
| 51KB Average Weekly Movement | 9.3% |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 51KB's share price has been volatile over the past 3 months.
Volatility Over Time: 51KB's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 207 | Jim Corbett | www.avitamedical.com |
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time.
AVITA Medical, Inc. Fundamentals Summary
| 51KB fundamental statistics | |
|---|---|
| Market cap | €209.25m |
| Earnings (TTM) | -€33.21m |
| Revenue (TTM) | €47.07m |
4.4x
P/S Ratio-6.3x
P/E RatioIs 51KB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 51KB income statement (TTM) | |
|---|---|
| Revenue | US$50.14m |
| Cost of Revenue | US$7.78m |
| Gross Profit | US$42.36m |
| Other Expenses | US$77.74m |
| Earnings | -US$35.38m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | -1.37 |
| Gross Margin | 84.48% |
| Net Profit Margin | -70.56% |
| Debt/Equity Ratio | 81.2% |
How did 51KB perform over the long term?
See historical performance and comparison